157 related articles for article (PubMed ID: 30450659)
1. Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms.
Brabrand M; Hansen KN; Laursen CB; Larsen TS; Vestergaard H; Abildgaard N
Eur J Haematol; 2019 Mar; 102(3):227-234. PubMed ID: 30450659
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms.
Ferrari A; Scandura J; Masciulli A; Krichevsky S; Gavazzi A; Barbui T
Eur J Haematol; 2021 Feb; 106(2):250-259. PubMed ID: 33135220
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients.
Venton G; Turcanu M; Colle J; Thuny F; Chebrek S; Farnault L; Mercier C; Ivanov V; Fanciullino R; Suchon P; Jarrot PA; Aissi K; Roche P; Cautela J; Arcani R; Costello R
Eur J Intern Med; 2019 Oct; 68():71-75. PubMed ID: 31421946
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients.
Jindamai Y; Rattarittamrong E; Phrommintikul A; Yongsmith L; Piriyakhuntorn P; Rattanathammethee T; Hantrakool S; Chai-Adisaksopha C; Tantiworawit A; Norasetthada L
Int J Hematol; 2020 Nov; 112(5):631-639. PubMed ID: 32700192
[TBL] [Abstract][Full Text] [Related]
5. Incidence of pulmonary hypertension in patients with chronic myeloproliferative disorders.
Gupta R; Perumandla S; Patsiornik Y; Niranjan S; Ohri A
J Natl Med Assoc; 2006 Nov; 98(11):1779-82. PubMed ID: 17128687
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of hemodynamic parameters among patients with myeloproliferative neoplasms and suspected pulmonary hypertension.
Khan NA; Ahuja KA; Wang X; Chaisson NF
Leuk Lymphoma; 2021 Jun; 62(6):1458-1465. PubMed ID: 33494630
[TBL] [Abstract][Full Text] [Related]
7. Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
Montani D; Thoré P; Mignard X; Jaïs X; Boucly A; Jevnikar M; Seferian A; Jutant EM; Cottin V; Fadel E; Simonneau G; Savale L; Sitbon O; Humbert M
Am J Respir Crit Care Med; 2023 Sep; 208(5):600-612. PubMed ID: 37311222
[No Abstract] [Full Text] [Related]
8. Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience.
Mattar MM; Morad MA; El Husseiny NM; Ali NH; El Demerdash DM
Ann Hematol; 2016 Oct; 95(10):1611-6. PubMed ID: 27468853
[TBL] [Abstract][Full Text] [Related]
9. A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms.
Rungjirajittranon T; Owattanapanich W; Ungprasert P; Siritanaratkul N; Ruchutrakool T
BMC Cancer; 2019 Feb; 19(1):184. PubMed ID: 30819138
[TBL] [Abstract][Full Text] [Related]
10. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
Michiels JJ; Berneman Z; Schroyens W; De Raeve H
Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
[TBL] [Abstract][Full Text] [Related]
11. Unexplained pulmonary hypertension in chronic myeloproliferative disorders.
Dingli D; Utz JP; Krowka MJ; Oberg AL; Tefferi A
Chest; 2001 Sep; 120(3):801-8. PubMed ID: 11555513
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseases.
García-Manero G; Schuster SJ; Patrick H; Martinez J
Am J Hematol; 1999 Feb; 60(2):130-5. PubMed ID: 9929105
[TBL] [Abstract][Full Text] [Related]
13. Myeloproliferative neoplasms: trends in incidence, prevalence and survival in Norway.
Roaldsnes C; Holst R; Frederiksen H; Ghanima W
Eur J Haematol; 2017 Jan; 98(1):85-93. PubMed ID: 27500783
[TBL] [Abstract][Full Text] [Related]
14. Increased incidence of another cancer in myeloproliferative neoplasms patients at the time of diagnosis.
Pettersson H; Knutsen H; Holmberg E; Andréasson B
Eur J Haematol; 2015 Feb; 94(2):152-6. PubMed ID: 25039361
[TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular events as presenting manifestations of Myeloproliferative Neoplasm.
Ong E; Barraco F; Nighoghossian N; Praire A; Desestret V; Derex L; Vighetto A; Biotti D
Rev Neurol (Paris); 2016 Nov; 172(11):703-708. PubMed ID: 28241944
[TBL] [Abstract][Full Text] [Related]
16. Association of Disease Subtype and Duration with Echocardiographic Evidence of Pulmonary Hypertension in Myeloproliferative Neoplasm.
Yaylali YT; Yilmaz S; Akgun-Cagliyan G; Kilic O; Kaya E; Senol H; Ozen F
Med Princ Pract; 2020; 29(5):486-491. PubMed ID: 32069470
[TBL] [Abstract][Full Text] [Related]
17. Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry.
Kaifie A; Kirschner M; Wolf D; Maintz C; Hänel M; Gattermann N; Gökkurt E; Platzbecker U; Hollburg W; Göthert JR; Parmentier S; Lang F; Hansen R; Isfort S; Schmitt K; Jost E; Serve H; Ehninger G; Berdel WE; Brümmendorf TH; Koschmieder S;
J Hematol Oncol; 2016 Mar; 9():18. PubMed ID: 26944254
[TBL] [Abstract][Full Text] [Related]
18. High rate of abnormal blood values and vascular complications before diagnosis of myeloproliferative neoplasms.
Enblom A; Lindskog E; Hasselbalch H; Hersby D; Bak M; Tetu J; Girodon F; Andréasson B
Eur J Intern Med; 2015 Jun; 26(5):344-7. PubMed ID: 25863408
[TBL] [Abstract][Full Text] [Related]
19. Myeloproliferative neoplasms (MPNs) have a significant impact on patients' overall health and productivity: the MPN Landmark survey.
Mesa R; Miller CB; Thyne M; Mangan J; Goldberger S; Fazal S; Ma X; Wilson W; Paranagama DC; Dubinski DG; Boyle J; Mascarenhas JO
BMC Cancer; 2016 Feb; 16():167. PubMed ID: 26922064
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary hypertension with massive megalosplenia: A case report.
Yi T; Ma W; Qiu J; Ding W
Medicine (Baltimore); 2019 Mar; 98(12):e14594. PubMed ID: 30896614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]